Latest News

New target for chronic pain treatment found

The enzyme PIP5K1C controls the activity of cellular receptors that signal pain, researchers have found. By reducing the enzyme, researchers showed that levels of a lipid called PIP2 is also lessened. They also found a compound that can dampen the activity of PIP5K1C. These findings could lead to a new kind of pain reliever for the more than 100 million people who suffer from chronic pain in the US.
View full story

Post your comment.


  • Newly evolved, uniquely human gene variants protect older adults from cognitive decline

  • Parental absence affects brain development in children

  • Aspirin targets key protein in neurodegenerative diseases

  • Could fish have consciousness? 'Emotional fever' experiment suggests they might

  • Threats against children during the separation process for women in abusive relationships

  • How funny is this word? The 'snunkoople' effect

  • DNA repair protein BRCA1 implicated in cognitive function and dementia

  • Risk-takers are smarter, according to a new study

  • Physical activity linked to better memory among older adults

  • Mosquito-borne virus may lead to severe brain infection